UChicago’s Pritzker School of Molecular Engineering Faculty boost vaccines and immunotherapies with machine learning to drive more effective treatments
Small molecules called immunomodulators can help create more effective vaccines and stronger immunotherapies to treat cancer.
But finding the molecules that instigate the right immune response is difficult —the number of drug-like small molecules has been estimated to be 1060, much higher than the number of stars in the visible universe.
In a potential first for the field of vaccine design, machine learning guided the discovery of new immune pathway-enhancing molecules and found one particular small molecule that could outperform the best immunomodulators on the market. The ...















